Walkner Condon Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $470K | Buy |
2,533
+321
| +15% | +$59.6K | 0.09% | 168 |
|
|
2025
Q1 | $464K | Buy |
2,212
+160
| +8% | +$33.5K | 0.09% | 171 |
|
|
2024
Q4 | $365K | Buy |
2,052
+142
| +7% | +$25.2K | 0.07% | 191 |
|
|
2024
Q3 | $377K | Buy |
1,910
+216
| +13% | +$42.7K | 0.08% | 188 |
|
|
2024
Q2 | $291K | Sell |
1,694
-999
| -37% | -$171K | 0.06% | 203 |
|
|
2024
Q1 | $490K | Buy |
2,693
+257
| +11% | +$46.8K | 0.1% | 153 |
|
|
2023
Q4 | $378K | Buy |
2,436
+182
| +8% | +$28.2K | 0.09% | 184 |
|
|
2023
Q3 | $336K | Buy |
2,254
+109
| +5% | +$16.2K | 0.09% | 173 |
|
|
2023
Q2 | $289K | Sell |
2,145
-848
| -28% | -$114K | 0.08% | 190 |
|
|
2023
Q1 | $477K | Buy |
2,993
+140
| +5% | +$22.3K | 0.13% | 138 |
|
|
2022
Q4 | $461K | Buy |
2,853
+344
| +14% | +$55.6K | 0.14% | 132 |
|
|
2022
Q3 | $337K | Buy |
2,509
+77
| +3% | +$10.3K | 0.11% | 151 |
|
|
2022
Q2 | $372K | Buy |
2,432
+448
| +23% | +$68.5K | 0.12% | 151 |
|
|
2022
Q1 | $322K | Buy |
+1,984
| New | +$322K | 0.09% | 169 |
|